Next Article in Journal
NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer
Previous Article in Journal
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2018, 11(2), 35; https://doi.org/10.3390/ph11020035

Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing

1
,
1
,
1
,
2,3
,
3,4
and
1,2,3,*
1
College of Marine Life and Fisheries, Huahai Institute of Technology, Lianyungang 222005, China
2
Marine Resources Development Institute of Jiangsu, Lianyungang 222005, China
3
Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Huaihai Institute of Technology, Lianyungang 222005, China
4
Verschuren Centre for Sustainability in Energy & the Environment, Cape Breton University, Sydney, NS B1P 6L2, Canada
*
Author to whom correspondence should be addressed.
Received: 8 March 2018 / Revised: 10 April 2018 / Accepted: 10 April 2018 / Published: 21 April 2018
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)
View Full-Text   |   Download PDF [15125 KB, uploaded 3 May 2018]   |  

Abstract

Enhancing the limit of detection (LOD) is significant for crucial diseases. Cancer development could take more than 10 years, from one mutant cell to a visible tumor. Early diagnosis facilitates more effective treatment and leads to higher survival rate for cancer patients. Rolling circle amplification (RCA) is a simple and efficient isothermal enzymatic process that utilizes nuclease to generate long single stranded DNA (ssDNA) or RNA. The functional nucleic acid unit (aptamer, DNAzyme) could be replicated hundreds of times in a short period, and a lower LOD could be achieved if those units are combined with an enzymatic reaction, Surface Plasmon Resonance, electrochemical, or fluorescence detection, and other different kinds of biosensor. Multifarious RCA-based platforms have been developed to detect a variety of targets including DNA, RNA, SNP, proteins, pathogens, cytokines, micromolecules, and diseased cells. In this review, improvements in using the RCA technique for medical biosensors and biomedical applications were summarized and future trends in related research fields described. View Full-Text
Keywords: rolling circle amplification (RCA); biosensor; clinical diagnostics; cancer rolling circle amplification (RCA); biosensor; clinical diagnostics; cancer
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gu, L.; Yan, W.; Liu, L.; Wang, S.; Zhang, X.; Lyu, M. Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing. Pharmaceuticals 2018, 11, 35.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top